IBDEI0Q7 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11773,1,4,0)
 ;;=4^N06.8
 ;;^UTILITY(U,$J,358.3,11773,2)
 ;;=^5015557
 ;;^UTILITY(U,$J,358.3,11774,0)
 ;;=N06.9^^46^573^41
 ;;^UTILITY(U,$J,358.3,11774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11774,1,3,0)
 ;;=3^Isolated proteinuria w/ unspecified morphologic lesion
 ;;^UTILITY(U,$J,358.3,11774,1,4,0)
 ;;=4^N06.9
 ;;^UTILITY(U,$J,358.3,11774,2)
 ;;=^5015558
 ;;^UTILITY(U,$J,358.3,11775,0)
 ;;=N07.0^^46^573^29
 ;;^UTILITY(U,$J,358.3,11775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11775,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ minor glomerular abnormality
 ;;^UTILITY(U,$J,358.3,11775,1,4,0)
 ;;=4^N07.0
 ;;^UTILITY(U,$J,358.3,11775,2)
 ;;=^5015559
 ;;^UTILITY(U,$J,358.3,11776,0)
 ;;=N07.1^^46^573^28
 ;;^UTILITY(U,$J,358.3,11776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11776,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ focal & seg glomerular lesions
 ;;^UTILITY(U,$J,358.3,11776,1,4,0)
 ;;=4^N07.1
 ;;^UTILITY(U,$J,358.3,11776,2)
 ;;=^5015560
 ;;^UTILITY(U,$J,358.3,11777,0)
 ;;=N07.2^^46^573^24
 ;;^UTILITY(U,$J,358.3,11777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11777,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ diffuse membranous glomrlneph
 ;;^UTILITY(U,$J,358.3,11777,1,4,0)
 ;;=4^N07.2
 ;;^UTILITY(U,$J,358.3,11777,2)
 ;;=^5015561
 ;;^UTILITY(U,$J,358.3,11778,0)
 ;;=N07.3^^46^573^25
 ;;^UTILITY(U,$J,358.3,11778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11778,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ diffuse mesangial prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,11778,1,4,0)
 ;;=4^N07.3
 ;;^UTILITY(U,$J,358.3,11778,2)
 ;;=^5015562
 ;;^UTILITY(U,$J,358.3,11779,0)
 ;;=N07.4^^46^573^23
 ;;^UTILITY(U,$J,358.3,11779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11779,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ diffus endocaplry prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,11779,1,4,0)
 ;;=4^N07.4
 ;;^UTILITY(U,$J,358.3,11779,2)
 ;;=^5015563
 ;;^UTILITY(U,$J,358.3,11780,0)
 ;;=N07.5^^46^573^26
 ;;^UTILITY(U,$J,358.3,11780,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11780,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ diffuse mesangiocap glomrlneph
 ;;^UTILITY(U,$J,358.3,11780,1,4,0)
 ;;=4^N07.5
 ;;^UTILITY(U,$J,358.3,11780,2)
 ;;=^5015564
 ;;^UTILITY(U,$J,358.3,11781,0)
 ;;=N07.6^^46^573^22
 ;;^UTILITY(U,$J,358.3,11781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11781,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ dense deposit disease
 ;;^UTILITY(U,$J,358.3,11781,1,4,0)
 ;;=4^N07.6
 ;;^UTILITY(U,$J,358.3,11781,2)
 ;;=^5015565
 ;;^UTILITY(U,$J,358.3,11782,0)
 ;;=N07.7^^46^573^27
 ;;^UTILITY(U,$J,358.3,11782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11782,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ diffuse crescentic glomrlneph
 ;;^UTILITY(U,$J,358.3,11782,1,4,0)
 ;;=4^N07.7
 ;;^UTILITY(U,$J,358.3,11782,2)
 ;;=^5015566
 ;;^UTILITY(U,$J,358.3,11783,0)
 ;;=N07.8^^46^573^30
 ;;^UTILITY(U,$J,358.3,11783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11783,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ oth morphologic lesions
 ;;^UTILITY(U,$J,358.3,11783,1,4,0)
 ;;=4^N07.8
 ;;^UTILITY(U,$J,358.3,11783,2)
 ;;=^5015567
 ;;^UTILITY(U,$J,358.3,11784,0)
 ;;=N07.9^^46^573^31
 ;;^UTILITY(U,$J,358.3,11784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11784,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ unsp morphologic lesions
 ;;^UTILITY(U,$J,358.3,11784,1,4,0)
 ;;=4^N07.9
 ;;^UTILITY(U,$J,358.3,11784,2)
 ;;=^5015568
